Sunshine Act of 2022

Bill: 117-hr-9378
Sponsor: full_name: Rep. Burgess, Michael C. [R-TX-26]
Introduced: 2022-12-01
Policy area: Health
Latest action: action_date: 2022-12-01
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:
action_date: 2022-12-01
action_desc: Introduced in House
text: <p><b>Sunshine Act of 2022</b></p> <p>This bill specifies that manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid or the Children's Health Insurance Program (CHIP) are not required to report peer-reviewed journals, journal reprints, journal supplements, medical conference reports, or medical textbooks that are provided to health care practitioners or teaching hospitals.</p>

tv_txt: I 117th CONGRESS 2d Session H. R. 9378 IN THE HOUSE OF REPRESENTATIVES December 1, 2022 Mr. Burgess (for himself and Mr. Bera ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.

1. Short title This Act may be cited as the Sunshine Act of 2022 . 2. Clarifying manufacturer transparency reporting requirements for certain transfers used for educational purposes (a) In general Section 1128G(e)(10)(B)(iii) of the Social Security Act (42 U.S.C. 1320a–7h(e)(10)(B)(iii)) is amended by inserting , including peer-reviewed journals, journal reprints, journal supplements, medical conference reports, and medical textbooks after patient use . (b) Effective date The amendment made by this section shall apply with respect to transfers of value made on or after the date of the enactment of this Act.